Some suggest that FDA should create a separate division of rare and neglected diseases within the Center for Drug Evaluation and Research to bring the proper expertise to bear on the analysis of drug applications intended to treat such maladies.
Harkin discusses the need for a dedicated FDA division for rare diseases.
Share
More from Tom Harkin
I thank the Senator for her important question. Her understanding is correct. The definition of homeless children and youth found at 42 U.S.C. Sec. 11434A is the definition we intend to apply to homeless children and families where those…
Good morning, everyone. The Senate Committee on Health, Education, Labor, and Pensions will please come to order.
Again, I thank the Senator for this clarifying question. Under this bill, State plans must include a certification that there are in effect in the State requirements that include the establishment of a grace period that allows homeless…
Other voices in this conversation
